Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions

RS McIntyre, M Alsuwaidan, BT Baune, M Berk… - World …, 2023 - Wiley Online Library
Treatment‐resistant depression (TRD) is common and associated with multiple serious
public health implications. A consensus definition of TRD with demonstrated predictive utility …

Omics approaches open new horizons in major depressive disorder: from biomarkers to precision medicine

F Stolfi, H Abreu, R Sinella, S Nembrini… - Frontiers in …, 2024 - frontiersin.org
Major depressive disorder (MDD) is a recurrent episodic mood disorder that represents the
third leading cause of disability worldwide. In MDD, several factors can simultaneously …

Assessment and management of cognitive and psychosocial dysfunctions in patients with major depressive disorder: A clinical review

A Fiorillo, B Carpiniello, S De Giorgi, S La Pia… - Frontiers in …, 2018 - frontiersin.org
Background: Full functional recovery is defined as a state in which patients are again able to
enjoy their usual activities, return to work, and take care of themselves, and it should …

Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of …

NB Rodrigues, RS McIntyre, O Lipsitz, DS Cha… - Journal of affective …, 2020 - Elsevier
Background Anhedonia is a trans-diagnostic, multidimensional phenotype that mediates
patient outcomes and suicidality. Convergent evidence suggests that ketamine may be …

Personal recovery self-report outcome measures in serious mental illness: A systematic review of measurement properties

S Felix, KM Valery, M Caiada, S Guionnet… - Clinical Psychology …, 2024 - Elsevier
Background Personal recovery represents a paradigm shift in mental healthcare. Validated
self-report outcome measures (PROMs) are needed to facilitate the transformation towards …

Predictors of changes in quality of life of patients with major depressive Disorder—A prospective naturalistic 3-Month Follow-Up study

V Dionisie, MG Puiu, M Manea… - Journal of Clinical …, 2023 - mdpi.com
Major depressive disorder (MDD) is one of the leading causes of disease burden worldwide
and affected patients frequently report impairments in quality of life (QoL). Therefore, the …

Trajectories and determinants of functional limitations in late-life depression: a 2-year prospective cohort study

S Wassink-Vossen, RM Collard, KJ Wardenaar… - European …, 2019 - cambridge.org
Background: In mental health research, functional recovery is increasingly valued as an
important outcome in addition to symptomatic remission. Methods: Course types of …

In pursuit of full recovery in major depressive disorder

M Vicent-Gil, M Serra-Blasco… - European Archives of …, 2023 - Springer
Many individuals with major depression disorder (MDD) who achieve remission of
depressive symptoms, do not perceive themselves as fully recovered. This study explores …

The relative importance of diagnostic specific and transdiagnostic factors in evaluating treatment outcome of depressed patients

M Zimmerman, JS Thompson, DM Mackin - Psychiatry research, 2022 - Elsevier
Determinations of the efficacy of treatments for depression most commonly are based on
changes in scores on symptom severity scales. This narrow symptom-focused approach …

[HTML][HTML] Deep immunophenoty** of circulating immune cells in major depressive disorder patients reveals immune correlates of clinical course and treatment …

F Stolfi, C Brasso, D Raineri, V Landra… - Brain, Behavior, & …, 2025 - Elsevier
Abstract Major Depressive Disorder (MDD) is a widespread psychiatric condition impacting
social and occupational functioning, making it a leading cause of disability. The diagnosis of …